Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine at the Icahn School of Medicine at Mount Sinai Hospital, discusses how patients benefit when healthcare providers look at the “whole picture” in advanced stage cancer treatment.
Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses concerns women with gynecologic cancer have regarding their prognosis.
Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses the importance of spouse and caregiver self care when tending to someone with lung cancer.
Areej El-Jawahri, MD, an oncologist at Massachusetts General Hospital, discusses how patients with cancer do not often have a full understanding of the terms and processes doctors describe during treatment.
Joseph Ravenell, MD, MS, from NYU Langone Medical Center, discusses access to screening among black men.
Kathy Jo Gutgsell, RN, MT-BC, music therapist at University Hospitals Seidman Cancer Center talks about how music can help patients with cancer.
Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.
Kathleen M. Madden, MSN, FNP-BC, AOCNP®, provides an overview of treatment of melanoma with new targeted therapies.
Women under 40 who find a suspicious lump in their breast often have their cancer fears dismissed and are told “you are too young for breast cancer,” according to Megan McCann, associate director of programs at the Young Survival Coalition. Here, she discusses breaking down that misconception that younger women can’t get breast cancer.
Samantha Ganey Aquino, MSN, AGPCNP-BC, discusses pain management for patients with cancer.
Jan Lewin, PhD, section chief of Speech Pathology and Audiology at The University of Texas MD Anderson Cancer Center, discusses the two different types of lymphedema and the importance of getting treated.
While eating during treatment for head and neck cancer may be uncomfortable, Giselle Carnaby, PhD, MPH, CCC-SLP, ASHA fellow and professor at University of Central Florida College of Health and Public Affairs, emphasizes that it is vitally important.
Maria Cabanillas, MD, explains that for people who are newly diagnosed with thyroid cancer, it is imperative that they know all the details about their cancer before heading into surgery.
After leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for the disease.
Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Mario E. Lacouture, MD, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.
After being diagnosed with breast cancer, Susan Rafte and her sister started The Pink Ribbons Project is a Houston-based nonprofit that provides surrounding communities with access to fundamental breast health services via awareness programs, fundraising events and community collaboration.
Paula Raska, a research associate from the Cleveland Clinic, discusses a study of patient navigation.
Freya R. Schnabel, MD, discusses the importance of choosing individualized treatment options for patients with breast cancer.
Joseph Ravenell, MD, MS, discusses some of the challenges with screening black men for colon cancer.
Holly Pederson, MD, discusses the unique contributions of nurses on her team.
Rajni Kannan discusses the role of nurses in skin cancer prevention education.
Samantha Ganey Aquino discusses results from a study of pain assessment.
Kathleen M. Madden discusses the management of adverse events (AEs) with BRAF and MEK inhibitors for the treatment of patients with melanoma.
Gwendolyn Quinn, PhD, discusses the importance of educating nurses and physicians about reproductive health.
Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Susan Hassmiller, PhD, RN, FAAN, senior advisor for nursing, Robert Wood Johnson Foundation, discusses what it means to
Smita Bhatia, MD, MPH, discusses the relationship between treatment for cancer and the development of other cancers.
Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center (MSK), discusses a study investigating the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
Kevin Oeffinger, MD, Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center, discusses the importance of cancer survivorship in the primary care setting.
